Denali Therapeutics CEO Ryan Watts' 2019 pay slips 17% to $5M
Denali Therapeutics reports 2019 executive compensation
By ExecPay News
Published: April 22, 2020
Denali Therapeutics reported fiscal year 2019 executive compensation information on April 22, 2020.
In 2019, four executives at Denali Therapeutics received on average a compensation package of $3.1M, a 30% decrease compared to previous year.
Average pay of disclosed executives at Denali Therapeutics
Ryan J. Watts, Chief Executive Officer, received $5M in total, which decreased by 17% compared to 2018. 65% of Watts' compensation, or $3.3M, was in option awards. Watts also received $312K in bonus, $567K in salary, $838K in stock awards, as well as $9.4K in other compensation.
Steve E. Krognes, Chief Financial Officer, received a compensation package of $2.5M, which decreased by 37% compared to previous year. 62% of the compensation package, or $1.6M, was in option awards.
Carole Ho, Chief Medical Officer, earned $2.5M in 2019, a 37% decrease compared to previous year.
Alexander O. Schuth, Chief Operating Officer, received $2.5M in 2019, which decreases by 37% compared to 2018.
Related executives
You may also like
Source: SEC filing on April 22, 2020.